Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Davis

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of the American College of Cardiology|January 30, 2007
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responsesMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Bioconjugate Chemistry|July 22, 2004
Cyclodextrin-modified polyethylenimine polymers for gene deliverySuzie H Pun, Nathalie C Bellocq, Aijie Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2012
Metalloenzyme-like catalyzed isomerizations of sugars by Lewis acid zeolitesRicardo Bermejo-Deval, Rajeev S Assary, Eranda Nikolla, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancerJoseph Chao, James Lin, Paul Frankel, et al.
Cancer Biology & Therapy|May 12, 2004
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesSuzie H Pun, Frederik Tack, Nathalie C Bellocq, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2006
Mechanical and dielectric properties of pure-silica-zeolite low-k materialsZijian Li, Mark C Johnson, Minwei Sun, et al.
Nature Medicine|October 6, 2009
Development of universal antidotes to control aptamer activitySabah Oney, Ruby T S Lam, Kristin M Bompiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2012
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growthMohammad Aminur Rahman, A R M Ruhul Amin, Xu Wang, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of the American College of Cardiology|January 30, 2007
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responsesMark E Davis, Christopher J Pemberton, Timothy G Yandle, et al.
Bioconjugate Chemistry|July 22, 2004
Cyclodextrin-modified polyethylenimine polymers for gene deliverySuzie H Pun, Nathalie C Bellocq, Aijie Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2012
Metalloenzyme-like catalyzed isomerizations of sugars by Lewis acid zeolitesRicardo Bermejo-Deval, Rajeev S Assary, Eranda Nikolla, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancerJoseph Chao, James Lin, Paul Frankel, et al.
Cancer Biology & Therapy|May 12, 2004
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesSuzie H Pun, Frederik Tack, Nathalie C Bellocq, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2006
Mechanical and dielectric properties of pure-silica-zeolite low-k materialsZijian Li, Mark C Johnson, Minwei Sun, et al.
Nature Medicine|October 6, 2009
Development of universal antidotes to control aptamer activitySabah Oney, Ruby T S Lam, Kristin M Bompiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2012
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growthMohammad Aminur Rahman, A R M Ruhul Amin, Xu Wang, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Pageof 12